Download
s00393-020-00886-0.pdf 436,25KB
WeightNameValue
1000 Titel
  • Ergebnisse der systematischen Literatursuche als Grundlage für die „evidenzbasierten Therapieempfehlungen für FMF-Patienten mit unzureichendem Ansprechen bzw. Unverträglichkeit auf Kolchizin“ der Gesellschaft für Kinder- und Jugendrheumatologie und der Deutschen Gesellschaft für Rheumatologie
1000 Titelzusatz
  • Results of the systematic literature search as basis for the “Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine” of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology
1000 Autor/in
  1. Sahr, T. |
  2. Kiltz, U. |
  3. Weseloh, C. |
  4. Kallinich, T. |
  5. Braun, J. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-09-30
1000 Erschienen in
1000 Quellenangabe
  • 79(9):943-951
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00393-020-00886-0 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647992/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Familial Mediterranean fever (FMF) is a genetic disease of childhood and adulthood which is relatively rare in Germany. It is characterized by recurrent febrile attacks, peritonitis, pleuritis and arthritis. The established treatment with colchicine is effective and well-tolerated by most patients; however, some patients do not adequately respond or do not tolerate this treatment. Biologics can be considered for some of these patients. The Society for Pediatric and Adolescent Rheumatology (GKJR) and the German Society for Rheumatology (DGRh) have agreed to develop joint recommendations for this specific clinical situation.!##!Aim!#!Implementation of a systematic literature search (SLR) on the basis of the EULAR recommendations published in 2016 as the foundation for the development of evidence-based treatment recommendations for FMF patients with insufficient response or intolerance to colchicine.!##!Methods!#!The SLR was performed using references from various databases as an update of the SLR carried out by EULAR up to 2014, whereby all articles must have been published between 1 January 2015 and 31 December 2017. The Rayyan abstract tool for the preselection and the classification of the Oxford Centre for Evidence Based Medicine 2009 were used for the preparation of the evidence tables.!##!Results!#!The search yielded 360 hits and after duplicate matching 263. A total of 88 publications were included (34%) and 102 excluded (39%), a review of the full publication was necessary for a further 73 (28%) and 43 were discussed more intensively. Finally, 64 publications (24%) remained. A total of 4 case-control studies, 31 cohort studies, 8 case series, 7 controlled studies (including 5 abstracts), 10 reviews, 4 meta-analyses and systematic reviews were accepted.!##!Discussion!#!The SLR was carried out in a scientifically accurate and transparent manner according to international standards. The SLR proved to be a good basis for a consensus on the 5 overarching principles and the 10 recommendations, so that the joint activity of the GKJR and DGRh was successfully and even promptly concluded. The recommendations are a solid basis for treating patients of all ages with FMF. The explanations on the problem of colchicine resistance play an important role here.
1000 Sacherschließung
lokal Adolescent [MeSH]
lokal Biologics
lokal Interleukin-1
lokal Rheumatology [MeSH]
lokal Colchicine/therapeutic use [MeSH]
lokal Adult [MeSH]
lokal Familial Mediterranean Fever/drug therapy [MeSH]
lokal Humans [MeSH]
lokal Europäische Liga gegen den Rheumatismus
lokal Familiäres Mittelmeerfieber
lokal Familial Mediterranean Fever/diagnosis [MeSH]
lokal Empfehlungen und Stellungnahmen von Fachgesellschaften
lokal Interleukin 1
lokal Familial Mediterranean fever
lokal Colchicine resistance
lokal Germany [MeSH]
lokal Colchicine/adverse effects [MeSH]
lokal Biological Products [MeSH]
lokal European League Against Rheumatism
lokal Child [MeSH]
lokal Kolchizin-Resistenz
lokal Biologika
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2FociwgVC4=|https://frl.publisso.de/adhoc/uri/S2lsdHosIFUu|https://frl.publisso.de/adhoc/uri/V2VzZWxvaCwgQy4=|https://frl.publisso.de/adhoc/uri/S2FsbGluaWNoLCBULg==|https://frl.publisso.de/adhoc/uri/QnJhdW4sIEou
1000 Hinweis
  • DeepGreen-ID: 2aea26e95c67447b95998033aefd1c0e ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6470036.rdf
1000 Erstellt am 2023-11-18T03:26:26.628+0100
1000 Erstellt von 322
1000 beschreibt frl:6470036
1000 Zuletzt bearbeitet 2023-12-01T11:01:54.609+0100
1000 Objekt bearb. Fri Dec 01 11:01:54 CET 2023
1000 Vgl. frl:6470036
1000 Oai Id
  1. oai:frl.publisso.de:frl:6470036 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source